EMPERY ASSET MANAGEMENT, LP – NeuroSense Therapeutics Ltd. Transaction History
EMPERY ASSET MANAGEMENT, LP portfolio value:
$47,000
portfolio value
EMPERY ASSET MANAGEMENT, LP quarter portfolio value change:
-42.17%
quarter
NeuroSense Therapeutics Ltd. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -35K | $0.3 | 160K | |
| Q2 2022 | share | 0.00% | 0 shares | -14K | $0.51 | 160K | |
| Q1 2022 | share | 0.00% | 0 shares | 81K | $0.6 | 160K | |
| Q4 2021 | share | Increase | 0.00% | 160K shares | 15K | $0.91 | 160K |